GenIP Information

GenIP helps universities, research organizations, and companies decide which technologies to back, and which partners are most likely to license or invest. Whether you have one invention or an entire portfolio, our PhD-level analysts deliver decision-grade evaluations in 10 business days. We use AI tools to accelerate research without sacrificing rigor: every report is prepared by our analysts under strict confidentiality. Why Organizations Choose GenIP: • Proven Scale: 7,000+ evaluations, 2M+ commercialization data points, and 300+ clients across 33+ countries. • End-to-End Solutions: Invention Evaluator (single technologies), Invention Prioritizer (portfolios), Invention Validator (demand testing), Invention Boost (partner outreach), Talent Search, and IP Intelligence with Cardinal IP. • 100% Confidential: NDAs signed prior to disclosure; client data is never used to train AI models. GenIP Plc is listed on the London Stock Exchange's AIM market (GNIP). 📩 Request a sample report at www.genip.ai